Long-term study of fluvoxamine: a new rapid-acting antidepressant.
This was a 1-year study of fluvoxamine in 31 depressed male and female patients with a history of chronic recurring depression of various types. Fluvoxamine has a rapid action with lifting of the mood often within 4-7 days, in a dosage range from 150 to 200 mg/day. Suicidal ideation in 8 patients disappeared within 5-6 days. There were few side effects. This new antidepressant seemed to be very effective especially in endogenous depression.